Related Experiment Videos
Insights
Diagnosing chronic hepatitis in children requires prompt investigation into its cause, especially distinguishing between autoimmune and hepatitis B virus (HBV)-associated chronic active hepatitis (CAH). Early diagnosis and treatment of autoimmune CAH can prevent long-term liver damage.
Area of Science:
- Pediatric Hepatology
- Immunology
- Gastroenterology
Background:
- Chronic hepatitis in children necessitates prompt investigation if symptoms persist over a month after acute hepatitis, or if relapsing hepatitis or chronic liver disease features are present.
- Excluding specific etiologies like hepatitis B virus (HBV), Wilson's disease, and alpha-1-antitrypsin deficiency is crucial for accurate diagnosis.
- Early histological confirmation by a pathologist is mandatory for effective management.
Purpose of the Study:
- To differentiate between autoimmune and HBV-associated chronic active hepatitis (CAH) in pediatric patients.
- To highlight the distinct clinical presentation and treatment response of autoimmune CAH in children compared to adults.
- To emphasize the importance of early diagnosis and intervention in preventing long-term sequelae like cirrhosis.
Main Methods:
- Clinical feature analysis and liver function test monitoring.
- Etiological investigations including exclusion of specific diseases (e.g., HBV, Wilson's disease).
- Histopathological examination for diagnosis and classification of chronic hepatitis.
- Immunological studies investigating T suppressor cell defects and antibody-dependent cytotoxicity in autoimmune CAH.
Main Results:
- Autoimmune CAH in children often presents acutely with a favorable response to immunosuppressants, allowing for potential therapy withdrawal if diagnosed early.
- HBV-associated CAH may show poor response to immunosuppressants, with undefined therapeutic regimens.
- Early diagnosis and treatment of autoimmune CAH may reduce the incidence of cirrhosis.
Conclusions:
- Distinguishing between autoimmune and HBV-associated CAH is critical for appropriate pediatric management.
- Early intervention in autoimmune CAH offers a better prognosis, potentially preventing cirrhosis.
- Further research into cellular interactions in hepatic fibrosis is needed for novel therapeutic strategies.
Abstract:
Chronic hepatitis in children should be suspected if clinical features and abnormal liver function tests persist for over one month following an episode of acute hepatitis, in children who present with relapsing hepatitis, or those presenting coincidentally with features of chronic liver disease. Specific investigation must be undertaken to define aetiology. For example, hepatitis B, Wilson's disease and alpha 1-antitrypsin deficiency must be excluded. Early histological diagnosis by an experienced histopathologist is mandatory. Chronic persistent hepatitis requires no therapy, but careful follow-up is desirable, especially for hepatitis B-positive cases. If the histological appearances are those of chronic active hepatitis, distinction between HBV-associated and autoimmune varieties is necessary. Autoimmune CAH in children differs from that in adults in that the onset is often acute, response to immunosuppressants usually favourable, and withdrawal of therapy may be successful, especially if diagnosis is established early before serious liver damage occurs. Evidence is presented to suggest that autoimmune CAH is associated with a genetic predisposition to autoimmune disease, characterized by both antigen-specific and antigen-independent T suppressor cell defects. An antibody-dependent non-T cell cytotoxicity operates against liver cell surface antigens. HBV CAH, on the other hand, may respond poorly to immunosuppressants and appropriate therapeutic regimens are not defined. There is some evidence to suggest that early diagnosis and institution of therapy in autoimmune CAH may lessen the incidence of cirrhosis on follow-up. Further studies to understand the interaction between hepatocytes, inflammatory cells and non-parenchymal cells in the process of hepatic fibrosis may provide the means of active intervention in this area in the future.